QL
LYEL icon

Quarry LP’s Lyell Immunopharma LYEL Stock Holding History

Quarry LP’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.52K Buy
+179
New +$3.24K ﹤0.01% 1489

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Quarry LP's LYEL Position: Q2 2026 in Review

Quarry LP opened a new position in Lyell Immunopharma (LYEL) in Q2 2026: 179 shares worth $2.52K. The stake represents ﹤0.01% of the portfolio and ranks #1489 among its holdings.

87 funds tracked by Wall St. Rank hold LYEL as of Q2 2026.

  • Quarry LP held 179 shares of Lyell Immunopharma worth $2.52K as of Q2 2026.
  • Lyell Immunopharma was a new Quarry LP position in Q2 2026.
  • Lyell Immunopharma made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1489 holding.
  • 87 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.